Nostos
5 known investors
Nostos Genomics develops genetic testing interpretation tools to improve the accuracy, speed, and accessibility of variant analysis for patients with rare and genetic diseases. The company addresses the diagnostic bottleneck in genetic sequencing by providing better information interpretation for patients and healthcare systems.
Investors · 5
In the news
- SNF Nostos Run 2026 - Stavros Niarchos Foundationsnf.org · 2026
- Nostos Genomics Raises €5M in Seed Funding Round | GenomeWebgenomeweb.com · 2022
- What does your genetic data tell about you? Berlin’s Nostos Genomics raises €5 million to speed up disease diagnosis - Tech.eutech.eu · 2022
- Nostos Genomics - $6M Seed Stage Venture | Startup Introsstartupintros.com · 2022
- Nostos Foundation - Nonprofit Explorer - ProPublicaprojects.propublica.org · 2013
- Nostos Genomics raised €5M in a seed round backed by 42CAP, Frontline Ventures, Amino Collective and Entrepreneur First. | Nordic 9nordic9.com